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Oxytocin (OT) is a neuropeptide synthesized primarily by neurons of the paraventricular 
and supraoptic nuclei of the hypothalamus. These neurons have axons that project into 
the posterior pituitary and release OT into the bloodstream to promote labor and lactation; 
however, OT neurons also project to other brain areas where it plays a role in numerous 
brain functions. OT binds to the widely expressed OT receptor (OTR), and, in doing so, it 
regulates homeostatic processes, social recognition, and fear conditioning. In addition to 
these functions, OT decreases neuroendocrine stress signaling and anxiety-related and 
depression-like behaviors. Steroid hormones differentially modulate stress responses 
and alter OTR expression. In particular, estrogen receptor β activation has been found to 
both reduce anxiety-related behaviors and increase OT peptide transcription, suggesting 
a role for OT in this estrogen receptor β-mediated anxiolytic effect. Further research is 
needed to identify modulators of OT signaling and the pathways utilized and to elucidate 
molecular mechanisms controlling OT expression to allow better therapeutic manipula-
tions of this system in patient populations.
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inTRODUCTiOn
The nonapeptide hormone, oxytocin (OT), has gained widespread attention as a potential therapeu-
tic agent in a myriad of disorders, including autism spectrum disorder, schizophrenia, and addiction 
(1). OT is produced primarily in the neurons of the hypothalamic paraventricular nucleus (PVN) 
and supraoptic nucleus [SON (2)], is released into systemic circulation, and plays an important role 
in lactation, parturition, maternal behavior, and pair-bond formation (3, 4). Additionally, OT is 
released from the PVN axon terminals that project throughout the brain into regions, such as the 
hippocampus, striatum, and amygdala (5), and has been implicated in the regulation of memory, 
stress, and social behaviors (1). In addition to traditional release across a synapse, OT is also released 
from neuron somas and dendrites and can reach nearby brain regions via volume transmission by 
Abbreviations: ACTH, adrenocorticotropic hormone; BNST, bed nucleus of the stria terminalis; CBP, cAMP response 
element-binding protein; CeA, central nucleus of the amygdala; CORT, corticosterone; CRF, corticotropin-releasing factor; 
DPN, diarylpropionitrile; ERα, estrogen receptor α; ERβ, estrogen receptor β; ERβKO, ERβ knockout; FST, forced swim test; 
GABA, γ-aminobutyric acid; HPA, hypothalamic–pituitary–adrenal; ICV, intracerebroventricular; LS, lateral septum; MPOA, 
medial preoptic area; OT, oxytocin; OTA, oxytocin receptor antagonist; OTKO, oxytocin knockout; OTR, oxytocin receptor; 
OTRKO, oxytocin receptor knockout; PVN, paraventricular nucleus of the hypothalamus; SRC, steroid receptor coactivator; 
VMH, ventromedial nucleus of the hypothalamus.
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diffusing across neural tissue (6). In this review, we focus on the 
function of OT in the brain and its modulation by estrogens.
OXYTOCin ReCePTORS: BRAin 
DiSTRiBUTiOn AnD FUnCTiOn
Oxytocin signals through OT receptors (OTRs), which are G pro-
tein-coupled receptors that, upon binding to OT, activate the Gq 
protein subunit and ultimately excite the cell. Autoradiographic 
studies have identified OTR expression in several regions of 
the rat brain, including the olfactory system, basal ganglia, hip-
pocampus, central amygdala, and hypothalamus (7). The genera-
tion of a knock-in mouse strain where Venus, a variant of yellow 
fluorescent protein, is under the regulation of the Otr promoter 
sequence, facilitated the identification of OTR expressing cells 
in additional brain regions, e.g., the median raphe nucleus and 
the lateral hypothalamus. This mouse model has been valuable in 
the identification of the phenotype of the cells expressing OTRs. 
For instance, OTRs have been found in serotonergic neurons (8), 
implicating serotonergic involvement in OTs anxiolytic effects in 
depression and anxiety.
Central OT is important in homeostatic processes, such as 
thermoregulation (9), food intake (10), and mating (11, 12). OT 
also plays an important role in maternal behavior. Female rats 
that received and exhibited high maternal care showed higher 
levels of OTRs in various limbic regions of the brain, including 
the bed nucleus of the stria terminalis (BNST), central nucleus 
of the amygdala (CeA), lateral septum (LS), PVN, and medial 
preoptic area (MPOA). Additionally, central administration of an 
OTR antagonist (OTA) completely eliminated the elevated lick-
ing and grooming behaviors seen in the high maternal behavior 
animals, suggesting that OTRs mediate maternal behaviors (13).
Additional insights into the function of OT and the OTR are 
gained from the examination of genetically engineered mouse 
models. Female OT knockout (OTKO) mice show normal 
parturition and maternal behavior but are unable to nurse their 
pups demonstrating that in the mouse OT is not necessary for 
maternal behavior or labor but is essential for milk ejection 
(14). Compared to the normal maternal behavior observed 
in OTKOs, OTR knockout (OTRKO) mice show deficits in 
maternal behaviors demonstrated by their longer latency for pup 
retrieval (15). OT signaling is also implicated in social behavior, 
and the OTKOs and OTRKOs both showed deficits in social 
memory. Wild-type animals investigate a novel conspecific for 
a longer period of time than a familiar animal, whereas OTKOs 
and OTRKOs show similar investigation times for both novel and 
familiar animals (15, 16). Although OTR levels remain unaltered 
in OTKOs (14, 16, 17), OTKOs demonstrated increased OTR 
sensitivity as measured by increased grooming following central 
OT administration (17).
Unlike OTKOs, OTRKO males display increased aggression 
in the resident-intruder task (15). It is possible that this elevated 
aggressive behavior in the OTRKOs is mediated by a lack of OT 
signaling in the CeA, since administration of OT into the CeA 
of male rats decreased aggressive behavior (18). Interestingly, 
OTKO offspring generated from a homozygous breeding scheme 
demonstrated an increased aggression phenotype as compared to 
those bred from heterozygous parents, suggesting that OT from 
the heterozygous dam can prevent the aggressive phenotype in 
the OTKO pups (15). Although these changes in behavior may 
relate to the absence of OT or the OTR, these phenotypic changes 
could be due to compensatory mechanisms that occur during 
development to overcome the absence of OT signaling.
Furthermore, selective knockout of OTRs in the LS showed 
that OT plays a bi-directional role in fear regulation dependent 
on social context. Animals exposed to a non-fearful conspecific 
[positive social encounter; (19)] or to social defeat [negative 
social encounter; (20)] during contextual fear conditioning 
showed reduced or increased fear, respectively, compared to 
controls. Intra-LS administration of OTA or of a virally linked 
Cre-recombinase to knockdown OTR expression prevented the 
altered fear response mediated by the social stimulus (19, 20). 
These data demonstrate that the OT/OTR system enhances 
memory of social interactions, reducing fear after positive and 
enhancing fear after negative social interactions.
Various factors influence OT signaling. OTRs are largely 
expressed centrally but their regional localization varies across 
species. For instance, mice and rats both express OTRs in the 
ventromedial nucleus of the hypothalamus [VMH (7, 8)], but 
OTRs are not expressed in this region in rabbits (7). These 
species-specific differences in localization may account for 
different responses to OT, for example, mice and rats respond 
differently to OT administration (21). Additionally, mice and 
humans show different OTR localization. For example, OTR-
Venus immunoreactivity was seen in the mouse hippocampus 
(8) but, in humans, OTRs were not localized to this area (22). 
OTR signaling also changes during development in rats with 
transient developmental patterns displayed postnatally, an 
adult-like expression pattern seen around postnatal day 21, and 
increased OTR quantities into adulthood (23). Additionally, OT 
signaling differs between males and females. Female rats were 
found to have fewer OTRs in the BNST, VMH, and medial amyg-
dala compared to males (24), and in humans, men and women 
were found to respond differently to intranasal OT administra-
tion (25, 26). These differences between males and females may 
relate to hormone differences, which alter OT signaling and are 
discussed in more detail in a later section.
OXYTOCin ReGULATiOn OF 
HYPOTHALAMiC–PiTUiTARY–ADRenAL 
AXiS
Oxytocin release from neurons of the PVN and the presence of 
OTRs within the PVN suggests the possibility that OT can directly 
modulate the stress reactive hypothalamic–pituitary–adrenal 
(HPA) axis. The HPA axis responds to stressors and activates 
neurons residing in the PVN causing increased synthesis and 
secretion of corticotropin-releasing factor (CRF). The release 
of CRF into the hypophyseal portal system enhances synthesis 
and release of adrenocorticotropic hormone (ACTH) from the 
anterior pituitary. In turn, ACTH acts on the adrenal cortex to 
stimulate release of glucocorticoids [cortisol in humans and 
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corticosterone (CORT) in rats and mice]. Increased levels of 
circulating glucocorticoids can further inhibit HPA axis activity 
via glucocorticoid and mineralocorticoid receptors in the brain as 
well as acting upon specific brain sites to modulate behaviors (27).
Oxytocin can putatively impact several sites within the HPA 
axis. PVN neurons that project to the median eminence release 
OT into the hypophyseal portal vasculature to stimulate adrenal 
glucocorticoid release by potentiating the actions of CRF at the 
anterior pituitary level in a similar fashion to the closely related 
neuropeptide vasopressin (28). By contrast, OT neurons in the 
PVN that project into the forebrain and release OT in response to 
stressors (29) exert anxiolytic actions (5). Intracerebroventricular 
(ICV) administration of OT decreases not only circulating CORT 
levels but also ACTH levels following exposure to stressors in rats 
(30, 31) and mice (32, 33), and central infusion of OT into the 
PVN inhibits HPA axis reactivity, via modulation of CRF neuronal 
activity (34). Using the restraint stress paradigm in association 
with OT administration (ICV), Windle et al. (31) demonstrated 
the presence of an OT-sensitive forebrain stress circuit involving 
the dorsal hippocampus, ventrolateral septum, and PVN (31).
Endogenous OT levels are also sufficient to alter HPA axis reac-
tivity. ICV injection of OTA showed elevated ACTH and CORT 
levels prior to behavioral testing suggesting that endogenous OT 
levels can suppress HPA axis reactivity (34, 35). Additionally, 
administration of OTA via retrodialysis into the PVN resulted in 
increased ACTH and CORT release indicating that endogenous 
OT can inhibit PVN neurons (35). Female OTKO mice show 
elevated CORT levels following acute and repeated shaker stress 
compared to wild-type littermates (33), demonstrating a defini-
tive role for OT in regulating HPA axis reactivity to stress.
Interestingly, OT also promotes social buffering in response to 
stress, similar to the effect seen with fear (19). Female prairie voles 
subjected to restraint stress demonstrated an increase in anxiety-
like behaviors and CORT levels when recovering alone but not 
when recovering with a male partner, which also corresponded to 
an increase in OT release in the PVN of these females. Intra-PVN 
OT injections reduced CORT and anxiety-related behaviors when 
animals recovered alone, whereas intra-PVA OTA administration 
prevented social buffering. These observations suggest that PVN 
OT signaling is necessary and sufficient for social buffering effects 
in response to stress in prairie voles (36).
OXYTOCin ReGULATiOn OF AnXieTY 
AnD DePReSSive BeHAviORS
Oxytocin is strongly implicated in social bond formation and 
social behavior [for review see Ref. (37)], but may also play a 
role in psychiatric disorders, such as anxiety and depression. The 
effect of OT in these disorders may be related to abnormal social 
behavior, but OT may also independently impact these disorders 
via regulation of the HPA axis. Dysregulation of the HPA axis and 
increased response to stressors are commonly seen in anxiety and 
mood disorders (38). In a clinical study with pediatric and adult 
participants, cerebrospinal fluid and plasma OT levels were found 
to be higher in participants that had lower anxiety (39). However, 
severe anxiety symptoms may be related to over-activation of the 
OT system as women with elevated OT levels were more likely to 
report being anxious on a daily basis (40). Reduced nocturnal lev-
els of OT have been reported in depressed individuals; however, 
numerous studies have also reported no differences compared to 
healthy controls (41). This variability across studies for anxiety 
and depression may relate to OT levels corresponding more to 
personality traits rather than symptoms of depression or anxiety 
(42). Despite these inconsistencies in data concerning psychiatric 
disorder OT levels, a recent meta-analysis suggests that OT may 
be beneficial in the treatment of anxiety and depression (43).
Oxytocin signaling during early development may contribute 
to later anxiety. Prairie vole pups exposed to a single injection of 
OT on postnatal day 1 demonstrated an increase in serotonergic 
axon density in the anterior hypothalamus, cortical amygdala, 
and VMH but not in the PVN or medial amygdala. Such effects 
on serotonergic neurons could be a mechanism by which OT 
affects emotional behaviors, since serotonin is strongly linked 
to mood, and serotonin dysregulation is seen in depression and 
anxiety disorders (44).
In adult animals, OT administration reduces anxiety-related 
behaviors in the elevated plus maze (30, 45, 46) and open field 
assay (8, 11). OT administration centrally (30), to the medial 
prefrontal cortex (46), to the CeA (11), and to the PVN (45) was 
sufficient to reduce anxiety-related behaviors. Chronic central 
OT administration reduced anxiety in rats bred for high levels 
of anxiety-related behaviors (47). Further support for the role 
of OT in reducing anxiety comes from studies of OTKO mice 
with OTKO females showing increased anxiety-related behaviors 
compared to their wild-type counterparts (32, 33). The effect of 
OT was sex dependent as male OTKOs showed reduced anxiety-
related behaviors (32, 48).
Oxytocin also reduces measures of depression in the forced 
swim test (FST) and tail suspension test. In FST, rats treated with 
an OT analog spent less time immobile and more time swim-
ming and climbing the walls of the chamber than saline-treated 
animals indicating an antidepressant effect (49). Similarly, ICV 
OT or OTA administration showed a dose-dependent decrease 
or increase in immobility in both assays, respectively (50, 51). 
Interestingly, the antidepressant effect of OT was not blocked by 
a selective OTA, suggesting that OTs antidepressant effects are 
not OTR mediated (50).
ReGULATiOn OF OXYTOCin FUnCTiOn 
BY STeROiD HORMOneS
Steroid hormones are a broad family of hormones that include the 
estrogens, androgens, progestins, mineralocorticoids, and gluco-
corticoids. These hormones can readily cross the cell membrane 
where they bind and activate their respective intracellular recep-
tors. Steroid receptor proteins have DNA and ligand-binding 
domains, and unliganded steroid receptors are maintained in an 
inactive state by a complex of chaperone proteins (52). Upon ligand 
binding, the receptors dimerize and translocate into the nucleus 
and bind DNA promoters and recruit cofactors and transcription 
machinery to promote gene transcription (53). Steroid hormones 
have been found to alter OT signaling. Estrogens can act in a 
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synergistic manner with OT, not only by enhancing its anxio-
lytic effects (54) but also by increasing OTR levels in the mouse 
brain (55). In humans, a single dose of estradiol was sufficient to 
increase plasma OT levels in women (56). Similarly, testosterone 
alters OTR expression differently depending on brain region 
(21). Progesterone is important in pregnancy maintenance and 
in vitro studies found that progesterone could inhibit OT binding 
to the OTR (57). Also, treatment with a synthetic glucocorticoid 
significantly altered OTR expression in various brain regions, 
such as the amygdala, BNST, and VMH (58).
Understanding OT regulation by sex steroids is important 
since anxiety and depressive disorders show a larger gender 
disparity (38), which may be related to circulating steroid hor-
mone levels. Testosterone has been shown to decrease HPA axis 
activity (59, 60), whereas estrogens can both increase (60, 61) or 
decrease (62, 63) HPA axis activity, and these alterations may in 
part be through modulations of OT activity. The differences in 
the observed effects of estrogens on behavior and neuroendo-
crine responses to stress may relate to its differential activity on 
ERα and ERβ. Activation of ERα can increase HPA axis activ-
ity, whereas activation of ERβ has the opposite effect (61, 64). 
Although ERα-mediated activity modulates OTR transcription, 
ERβ-mediated activity has been found to alter Ot mRNA levels 
(65, 66). Moreover, androgen modulation of OT appears to be 
mediated in part by the testosterone metabolite 3β-diol, which 
activates ERβ to allow binding to the Ot promoter to increases 
Ot mRNA (67).
eSTROGen ReCePTOR β AnD OXYTOCin 
inTeRACTiOnS in ReGULATiOn HPA 
AXiS AnD AnXieTY-ReLATeD BeHAviORS
Activation of ERβ reduces HPA axis activity, as seen by reduc-
tions in ACTH levels and CORT levels, in mice (68) and rats (60, 
69, 70) following a stressor. ERβ receptors are expressed widely 
throughout the brain and often overlap with ERα expression 
(71), except in the PVN of rats where only ERβ is expressed (72). 
Interestingly, approximately 85% of OT neurons in the PVN 
co-express ERβ (72), and activation of ERβ within the PVN, 
with the ERβ-specific agonist diarylpropionitrile (DPN) or tes-
tosterone metabolite 3β-diol, reduces HPA axis activity following 
FiGURe 1 | Overview of estrogen receptor β (eRβ) action in oxytocin neurons of the paraventricular nucleus (Pvn) and oxytocin signaling. (A) ERβ 
signaling in PVN oxytocinergic neurons. (1) Estrogen enters the cell and binds to inactive ERβ. In its inactive form, ERβ is bound to a complex of chaperone proteins. 
(2) Upon binding its ligand, ERβ dimerizes. (3) The dimerized receptor binds to the composite hormone response element (cHRE) of the oxytocin promoter. 
Co-activators, such are SRC-1 and CBP, are recruited along with the transcription machinery to promote transcription. (4) Ultimately, the oxytocin peptide is 
produced. (B) Oxytocin signaling in the brain. Oxytocin is produced in neurons of the PVN and supraoptic nucleus (SON). Oxytocin neurons from both regions 
project to the posterior pituitary (P Pit). In addition to this release, the PVN also sends oxytocin projections throughout the brain (5). ERβ is expressed in 
approximately 85% of neurons in the rodent PVN but not in the SON (72). This suggests that ERβ could play a role in increasing oxytocin production in regions 
important in responding to stress and can subsequently influence brain areas that express oxytocin receptors [shown in blue; (8, 13)]. BNST, bed nucleus of the stria 
terminalis; DR, dorsal raphe nucleus; LS, lateral septum; MnR, median raphe nucleus; PFC, prefrontal cortex.
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restraint stress in rats (61, 73). Treatment with estradiol increases 
Ot mRNA expression in the brains of wild-type mice, but not 
in ERβ knockout (ERβKO) mice in both males (65) and females 
(66). This ERβ-mediated increase in Ot mRNA was specific to the 
PVN and not seen in the MPOA, SON (65), medial amygdala, or 
VMH (66).
The substantial overlap in the distribution of ERβ and OT 
in the PVN suggests a potential interaction between the two 
in the regulation of HPA axis activity. As previously discussed, 
activation of ERβ reduced HPA axis reactivity and anxiety-like 
behaviors in rats and mice (64, 68, 70). ICV treatment with 
OTA, however, blocked the ERβ agonist-mediated reduction 
of anxiety-related behaviors and CORT secretion (70), suggest-
ing interaction between ERβ signaling pathways and OTergic 
pathways in the control of anxiety-related behaviors and HPA 
axis reactivity in stress. Currently, the mechanisms involved in 
the crosstalk between these two pathways are not completely 
understood.
Recent studies have begun to investigate the complex 
interaction between ERβ and the Ot promoter. Using a mouse 
hypothalamic cell line expressing ERβ and OT, Sharma et al. (74) 
demonstrated Ot promoter occupancy by ERβ. The Ot promoter 
has a composite hormone response element, which allows for 
steroid receptor binding and Ot gene transcription regulation 
by ERs and other members of the nuclear receptor family but 
not the other steroid hormone receptors (75). Treatment of 
a neuronal cell line with the ERβ agonists, 3β-diol, DPN, or 
estradiol, elicited increases in Ot mRNA levels and Ot promoter 
occupancy (67, 74). In tandem with ERβ occupancy of the Ot 
promoter, cAMP response element-binding protein (CBP) and 
steroid receptor coactivator (SRC)-1 were found to occupy the 
Ot promoter, leading to increased acetylation of histone H4 in 
the presence of 3β-diol. Taken together, the data suggest that in 
the presence of 3β-diol, ERβ binds the Ot promoter and recruits 
ligand-dependent coactivator SRC-1, which binds CBP, and 
forms a functional complex that acetylates histone H4 to drive Ot 
gene expression (74). The role of ERβ related to OT signaling at 
the molecular level and its larger role in OT signaling throughout 
the brain are summarized in Figure 1. Further studies are needed 
to determine the extent of the binding of ERβ to the Ot promoter, 
the co-activators recruited, and how this interaction modulates 
HPA axis function in vivo.
COnCLUSiOn
Oxytocin has a wide range of roles in the brain and allows interest-
ing and important directions for research. Current data suggest 
that the OT neurons of the PVN provide the principal OTergic 
innervation of the forebrain. The function of OT, through OTRs, 
is regionally specific; however, the localization of OTRs varies 
across species, age, and sex, so separating the effect of these vari-
ables is necessary to determine how animal studies translate to 
humans. Modulators of the OT system, particularly the steroid 
hormones, also provide additional regulatory targets since OT 
modulates HPA axis reactivity and participates in many diverse 
functions. In particular, ERβ is expressed by many neurons of 
the PVN, and ERβ activation increases OT synthesis and reduces 
anxiety and neuroendocrine responses in animals. Hence, such 
targets may be fruitful directions for future focus.
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